Journal profile · HEMATOLOGY
Hamostaseologie
ISSN 0720-9355 · eISSN 2567-5761 · Schattauer GmbH · GERMANY · Bimonthly · Founded 1981
Hamostaseologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.3; hybrid open access; review 6–12 weeks (community reports); community-reported acceptance: easy; 270 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hamostaseologie is published by Schattauer GmbH and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Platelet Disorders and Treatments, Hemophilia Treatment and Research and Venous Thromboembolism Diagnosis and Management, together about 37.6% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Hämostaseologie is an interdisciplinary specialist journal on the complex topics of haemorrhages and thromboembolism and is aimed not only at haematologists, but also at a wide range of specialists from clinic and practice. The readership consequently includes both specialists for internal medicine as well as for surgical diseases.
Source: LetPub
Research area (LetPub): HEMATOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Platelet Disorders and TreatmentsMedicine13.8%
- Hemophilia Treatment and ResearchMedicine12.6%
- Venous Thromboembolism Diagnosis and ManagementMedicine11.2%
- Blood Coagulation and Thrombosis MechanismsMedicine9.2%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine6.4%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.6%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine5%
- Atrial Fibrillation Management and OutcomesMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.3LetPub ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.56LetPub ·
- SNIP 2026-06
- 0.9LetPub ·
- h-index
- 29LetPub ·
- h-index
- 46OpenAlex ·
- i10-index
- 409OpenAlex ·
- 2-year mean citedness
- 0.72OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 5.97%LetPub ·
Volume
- Articles per year
- 42LetPub ·
Articles by year OpenAlex count · 3,812 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 237 | 32 | 24 |
| 2025 | 270 | 64 | 129 |
| 2024 | 281 | 89 | 416 |
| 2023 | 247 | 76 | 300 |
| 2022 | 74 | 58 | 524 |
| 2021 | 212 | 52 | 1,119 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Schattauer GmbH
- Country or region
- GERMANY
- Language
- German
- Frequency
- Bimonthly
- Founded
- 1981
- ISSN
- 0720-9355
- Electronic ISSN
- 2567-5761
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Hamostaseologie
What CAS zone is Hamostaseologie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hamostaseologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hamostaseologie?
The latest impact factor listed by LetPub is 2.3; CiteScore 3.8, h-index 46.
How long does peer review take at Hamostaseologie?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Hamostaseologie?
According to LetPub and DOAJ records, Hamostaseologie is indexed in SCIE and Scopus.
Is Hamostaseologie open access, and what is the APC?
Hamostaseologie is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .